A DNA methylation signature associated with aberrant promoter DNA hypermethylation of DNMT3B in human colorectal cancer

European Journal of Cancer

Volumn 48, Issue 14, 2012, Pages 2270-2281

  Huidobro, Covadonga ^a   Urdinguio, Rocío G ^a   Rodríguez, Ramón María ^a   Mangas, Cristina ^a   Calvanese, Vincenzo ^b   Martínez Camblor, Pablo ^c   Ferrero, Cecilia ^a   Parra Blanco, Adolfo ^d   Rodrigo, Luis ^d   Obaya, Álvaro J ^a   Suárez Fernández, Laura ^a   Astudillo, Aurora ^a   Hernando, Henar ^e   Ballestar, Esteban ^e   Fernández, Agustín F ^a   Fraga, Mario F ^a,b  

^a DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^b CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^c OIB   (Spain)

^d HUCA   (Spain)

^e BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

Author keywords

Colon cancer; DNA methylation; DNMT3B

Indexed keywords

DNA METHYLTRANSFERASE 3B;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; COLORECTAL CANCER; DNA METHYLATION; FEMALE; GENE REPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN GENOME; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; AZACITIDINE; COLORECTAL NEOPLASMS; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; DOWN-REGULATION; ENZYME INHIBITORS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKOUT TECHNIQUES; HCT116 CELLS; HT29 CELLS; HUMANS; MALE; MIDDLE AGED; PROMOTER REGIONS, GENETIC; TRANSFECTION;

EID: 84865145263     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2011.12.019     Document Type: Article

References (27)

1. A.P. Feinberg, and B. Tycko The history of cancer epigenetics Nat Rev Cancer 4 2 2004 143 153
2. M. Esteller Cancer epigenomics: DNA methylomes and histone-modification maps Nat Rev Genet 8 4 2007 286 298
3. M. Esteller Epigenetics in cancer N Engl J Med 358 11 2008 1148 1159
4. H.G. Linhart, H. Lin, and Y. Yamada Dnmt3b promotes tumorigenesis in vivo by gene-specific de novo methylation and transcriptional silencing Genes Dev 21 23 2007 3110 3122
5. A. Ahluwalia, J.A. Hurteau, R.M. Bigsby, and K.P. Nephew DNA methylation in ovarian cancer. II. Expression of DNA methyltransferases in ovarian cancer cell lines and normal ovarian epithelial cells Gynecol Oncol 82 2 2001 299 304
6. I. Girault, S. Tozlu, R. Lidereau, and I. Bieche Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas Clin Cancer Res 9 12 2003 4415 4422
7. S. Mizuno, T. Chijiwa, and T. Okamura Expression of DNA methyltransferases DNMT1, 3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia Blood 97 5 2001 1172 1179
8. Y. Qu, G. Mu, and Y. Wu Overexpression of DNA methyltransferases 1, 3a, and 3b significantly correlates with retinoblastoma tumorigenesis Am J Clin Pathol 134 5 2010 826 834
9. M.M. Rahman, Z.R. Qian, and E.L. Wang DNA methyltransferases 1, 3a, and 3b overexpression and clinical significance in gastroenteropancreatic neuroendocrine tumors Hum Pathol 41 8 2010 1069 1078
10. J.D. Roll, A.G. Rivenbark, W.D. Jones, and W.B. Coleman DNMT3b overexpression contributes to a hypermethylator phenotype in human breast cancer cell lines Mol Cancer 7 2008 15
11. R.K. Palakurthy, N. Wajapeyee, and M.K. Santra Epigenetic silencing of the RASSF1A tumor suppressor gene through HOXB3-mediated induction of DNMT3B expression Mol Cell 36 2 2009 219 230
12. K. Nosho, K. Shima, and N. Irahara DNMT3B expression might contribute to CpG island methylator phenotype in colorectal cancer Clin Cancer Res 15 11 2009 3663 3671
13. C.A. Eads, K.D. Danenberg, and K. Kawakami CpG island hypermethylation in human colorectal tumors is not associated with DNA methyltransferase overexpression Cancer Res 59 10 1999 2302 2306
14. H. Lin, Y. Yamada, and S. Nguyen Suppression of intestinal neoplasia by deletion of Dnmt3b Mol Cell Biol 26 8 2006 2976 2983
15. M. Fanelli, S. Caprodossi, and L. Ricci-Vitiani Loss of pericentromeric DNA methylation pattern in human glioblastoma is associated with altered DNA methyltransferases expression and involves the stem cell compartment Oncogene 27 3 2008 358 365
16. T.J. Ley, L. Ding, and M.J. Walter DNMT3A mutations in acute myeloid leukemia N Engl J Med 363 25 2010 2424 2433
17. I. Rhee, K.E. Bachman, and B.H. Park DNMT1 and DNMT3b cooperate to silence genes in human cancer cells Nature 416 6880 2002 552 556
18. M. Bibikova, Z. Lin, and L. Zhou High-throughput DNA methylation profiling using universal bead arrays Genome Res 16 3 2006 383 393
19. V. Calvanese, E. Lara, and B. Suarez-Alvarez Sirtuin 1 regulation of developmental genes during differentiation of stem cells Proc Natl Acad Sci USA 107 31 2010 13736 13741
20. P. Martínez-Camblor, and N. Corral A general bootstrap algorithm for hypothesis testing J Stat Plan Infer 142 2011 589 600
21. A.M. Khatib, G. Siegfried, and A. Prat Inhibition of proprotein convertases is associated with loss of growth and tumorigenicity of HT-29 human colon carcinoma cells: importance of insulin-like growth factor-1 (IGF-1) receptor processing in IGF-1-mediated functions J Biol Chem 276 33 2001 30686 30693
22. P.W. Hollenbach, A.N. Nguyen, and H. Brady A comparison of azacitidine and decitabine activities in acute myeloid leukemia cell lines PLoS ONE 5 2 2010 e9001
23. K.D. Robertson, E. Uzvolgyi, and G. Liang The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors Nucleic Acids Res 27 11 1999 2291 2298
24. A.E. Ibrahim, M.J. Arends, and A.L. Silva Sequential DNA methylation changes are associated with DNMT3B overexpression in colorectal neoplastic progression Gut 60 4 2011 499 508
25. K. Nakayama Furin: a mammalian subtilisin/Kex2p-like endoprotease involved in processing of a wide variety of precursor proteins Biochem J 327 Pt 3 1997 625 635
26. N. Scamuffa, G. Siegfried, and Y. Bontemps Selective inhibition of proprotein convertases represses the metastatic potential of human colorectal tumor cells J Clin Invest 118 1 2008 352 363
27. D.E. Bassi, H. Mahloogi, R. Lopez De Cicco, and A. Klein-Szanto Increased furin activity enhances the malignant phenotype of human head and neck cancer cells Am J Pathol 162 2 2003 439 447